Skip to main content
AMCP 2025 Main banner
Back

Legislative and Regulatory Trends

(L3) Federal Legislative and Regulatory Update

Tuesday, April 1, 2025
3:15 PM – 4:30 PM CST
Location: Grandballroom B
CPE
ACPE UAN:0233-0000-25-013-L03-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
Join members of AMCP’s Government Affairs team for a discussion on federal legislation and regulations relevant to the issues facing managed care pharmacy. This session will focus on AMCP’s top-priority issues, including prescription digital therapeutics (PDTs), value-based arrangements in Medicaid, access to biosimilars, and implementation of the Inflation Reduction Act, along with other federal policy actions under consideration by Congress and the Administration regarding pharmacy benefit managers, Medicare, Medicaid, and more.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Identify important healthcare legislation and regulations passed in 2024 and their major provisions.
  2. Describe at least two federal health legislative proposals put forward for 2025.
  3. Summarize the Trump administration’s potential regulatory actions that will impact the practices of managed care pharmacy professionals and teams.